title: Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.
authors.affiliation: Hematology Division, Università Degli Studi Di Torino, Turin, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Cerrano
authors.affiliation: Hematology Division, Università Degli Studi Di Torino, Turin, Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: Crisà
authors.affiliation: AOU San Luigi Gonzaga, SCDU Internal Medicine II, Orbassano, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Gottardi
authors.affiliation: Hematology Division, Università Degli Studi Di Torino, Turin, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Aguzzi
authors.affiliation: Hematology Division, Università Degli Studi Di Torino, Turin, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Boccadoro
authors.affiliation: Hematology Division, Università Degli Studi Di Torino, Turin, Italy.
authors.forename: Dario
authors.initials: D
authors.lastname: Ferrero
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015321:Gene Rearrangement; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D050783:Proto-Oncogene Proteins c-ets / Q000235:genetics; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics*; D012074:Remission Induction; D012097:Repressor Proteins / Q000235:genetics; D016896:Treatment Outcome; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate; D047428:Protein Kinase Inhibitors; D050783:Proto-Oncogene Proteins c-ets; D020797:Receptor, Platelet-Derived Growth Factor beta; D012097:Repressor Proteins; D000097764:ETS Translocation Variant 6 Protein